Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection

Surg Endosc. 2009 Aug;23(8):1818-24. doi: 10.1007/s00464-008-0265-6. Epub 2009 Jan 1.

Abstract

Purpose: The aim of this study was to compare the outcomes of laparoscopic surgery with those of open resection in patients with extraperitoneal rectal cancer.

Methods: Five hundred forty-four patients with extraperitoneal rectal cancer who underwent curative resection between 1996 and 2007 were included. Patients were divided into a laparoscopic surgery group (LAP, n = 170) and an open surgery group (OPEN, n = 374).

Results: Morbidity requiring surgical correction was 5.8% in the LAP group and 4.8% in the OPEN group (p = 0.75). The anastomotic leakage rate was similar in both groups (5.7% in both; p = 0.98). Differences were found in preoperative carcinoembryonic antigen (CEA) (LAP group 4.6 ng/ml, OPEN group 7.7 ng/ml, p = 0.001), sphincter preservation (LAP group 82.9%, OPEN group 69.8%, p = 0.001), and mean distance from anal verge (LAP group 4.6 cm, OPEN group 5.2 cm, p = 0.002). Local recurrence and metastasis were similar by stage.

Conclusions: The results of this study show that laparoscopic resection of extraperitoneal rectal cancer was safe and effective.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / pathology
  • Adenocarcinoma / radiotherapy
  • Adenocarcinoma / surgery*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Disease Progression
  • Disease-Free Survival
  • Elective Surgical Procedures
  • Female
  • Fluorouracil / administration & dosage
  • Follow-Up Studies
  • Humans
  • Laparoscopy*
  • Laparotomy*
  • Levamisole / administration & dosage
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Postoperative Complications / epidemiology
  • Prospective Studies
  • Radiotherapy, Adjuvant
  • Rectal Neoplasms / drug therapy
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / radiotherapy
  • Rectal Neoplasms / surgery*
  • Tegafur / administration & dosage
  • Treatment Outcome

Substances

  • Tegafur
  • Levamisole
  • Fluorouracil